Finally, WHO has some good news for 213 covid-19 impacted countries
Category: #health  | By Nikita Chaurasia  | Date: 2020-09-04 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Finally, WHO has some good news for 213 covid-19 impacted countries

The World Health Organization on Wednesday reported that widely available and low-cost corticosteroids can aid covid-19 positive patients suffering from serious symptoms. The body also warned against the use of corticosteroids on patients with non-severe symptoms.

As per the scientific evidences from the eight randomized clinical trials, WHO suggests systemic corticosteroid may decrease 28-day mortality in covid-19 patients at critical stage. About 87 less deaths per 1000 patients were recorded using this steroid an about 67 less deaths per 1,000 patients in patients with severe disease.

WHO developed the cure in collaboration with Magic Evidence Ecosystem Foundation, a non-profit organization which provides methodologic support for developing and disseminating living guidance for covid-19 drug treatment.

In June this year, WHO released the outcomes of initial clinical trials conducted at Oxford University, showing dexamethasone to be lifesaving for severely ill covid-19 patients. For patients on ventilators, the treatment reduced deaths by a third and for patients requiring only oxygen, the death toll dropped by a fifth.

Moreover, early lab studies from a team of pharmacologists and researchers showed promise for an ‘out of the box’ alternative, a plant-based drug for treating coronavirus. The team found that an edible weed could potentially assist in inhibiting the viral infection, cite credible sources.

WHO on the matter said that there are still a lot of uncertainties regarding covid-19 treatment modalities and there are many avenues which need to be explored. WHO stated that lot of variables exhibit long-term impact of systemic corticosteroids in covid-19 survivors and will serve as important references for the future.

WHO also said that investigational therapies including remdesivir should be compared with systemic corticosteroids or assessed together with systemic corticosteroids instead of systemic corticosteroids alone.

Source: https://www.livemint.com/news/india/some-readily-available-steroids-can-be-life-saving-in-severe-covid-cases-who-11599101820424.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Fintech firm PayPal to shed around 2000 staff as global economy plummets

Fintech firm PayPal to shed around 2000 staff as global economy plummets

By Nikita Chaurasia

PayPal, the U.S.-based fintech giant, has reportedly announced that it will cut nearly 2000 jobs, approximately 7% of its workforce, as it turns the latest prominent tech company to shed staff in a bid to cut costs. The online payments provider cl...

EasyJet sees a rise in bookings as customers plan their next vacations

EasyJet sees a rise in bookings as customers plan their next vacations

By Nikita Chaurasia

British multinational low-cost airline group, EasyJet, has reported a record surge in bookings for the month of January as people prioritized their travel plans for the coming year. The news comes as airlines world over start to show signs that they&...

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

By Nikita Chaurasia

Dr. Reddy's Laboratories Ltd. and Cipla Ltd. surpassed Aurobindo Pharma to rank as the 2nd and 3rd largest drug manufacturers in India by sales in the three months that ended on September 30. This was the first change in the pecking order of the ...